Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

N-Cadherin antibody (Cytoplasmic Domain)

This anti-N-Cadherin antibody is a Mouse Monoclonal antibody detecting N-Cadherin in WB, IF and FACS. Suitable for Human.
Catalog No. ABIN6936892

Quick Overview for N-Cadherin antibody (Cytoplasmic Domain) (ABIN6936892)

Target

See all N-Cadherin (CDH2) Antibodies
N-Cadherin (CDH2) (Cadherin 2 (CDH2))

Reactivity

  • 148
  • 101
  • 67
  • 21
  • 17
  • 14
  • 9
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Host

  • 102
  • 57
  • 4
  • 2
  • 2
  • 1
Mouse

Clonality

  • 93
  • 74
  • 1
Monoclonal

Conjugate

  • 81
  • 18
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This N-Cadherin antibody is un-conjugated

Application

  • 114
  • 61
  • 42
  • 42
  • 30
  • 28
  • 16
  • 15
  • 14
  • 13
  • 9
  • 9
  • 4
  • 3
  • 2
  • 2
  • 1
Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS)

Clone

13A9
  • Binding Specificity

    • 20
    • 15
    • 15
    • 8
    • 6
    • 6
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cytoplasmic Domain

    Specificity

    Recognizes a protein of ~140 kDa, identified as N-Cadherin (NCAD), also known as CD325. NCAD is a member of the Cadherin superfamily, and consists of five extracellular repeats, a transmembrane domain and a cytoplasmic domain. CD325 deficient mice die at day 10 of gestation and embryos display major heart defects and malformed neural tubes and somites. Consistent with this, CD325 has been implicated in several aspects of cardiac development including the precardiac mesoderm, establishment of left-right symmetry and cardiac looping morphogenesis. Furthermore, CD325 is normally involved in inducing cell cycle arrest and its expression is frequently deregulated in cancer cells.Studies have linked N-cadherin to cancer metastasis by showing the aggressive tumor cells had preferentially turned on N-cadherin as opposed to E- or P-cadherin.

    Cross-Reactivity (Details)

    Human and Mouse. Others not known.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant human N-cadherin cytoplasmic domain

    Isotype

    IgG1 kappa
  • Application Notes

    Known_Application: Flow Cytometry (1-2 μg/million cells), ,Immunofluorescence (1-2 μg/mL), ,Western Blotting (1-2 μg/mL), ,Optimal dilution for a specific application should be determined.

    Positive_Control: HeLa or HUVEC cells. Heart, Pancreas or Cerebral Cortex

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Preservative

    Azide free

    Storage

    -20 °C,-80 °C

    Storage Comment

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Expiry Date

    24 months
  • Target

    N-Cadherin (CDH2) (Cadherin 2 (CDH2))

    Alternative Name

    CDH2

    Background

    Cadherin-2 N cadherin neuronal, Cadherin-2 type 1, Cadherin-2, Calcium dependent adhesion protein neuronal, CD325, CDH2, CDHN, CDw325, N-Cadherin, NCAD,N-Cadherin / Cadherin-2 / CD325 (NCAD)
    Cellular localisation: Cell surface

    Molecular Weight

    130-140kDa

    Gene ID

    1000, 464829

    UniProt

    P19022

    Pathways

    Regulation of Muscle Cell Differentiation, Cell-Cell Junction Organization, Synaptic Membrane
You are here:
Chat with us!